| Autor: |
Kaiguri PM; Kenya Medical Research Institute, P.O. Box 54840, Nairobi., Okoth FA, Lida F, Matsumura N, Tuei J, Mathenge EG, Kasomo A, Ireri E, Kamati GM, Osidiana VO, Owino NR, Kuiundu JM, Njuguna AW, Tukei PM, Yano M, Fujino T, Yatsuhashi H, Koga M, Hamada R, Fukui T, Nagatomo M |
| Jazyk: |
angličtina |
| Zdroj: |
African journal of health sciences [Afr J Health Sci] 1996 May; Vol. 3 (2), pp. 51-5. |
| Abstrakt: |
We undertook a study on selected samples from patients who had presented with viral hepatitis and conditions of the liver (liver cirrhosis, chronic hepatitis and hepatocellular carcinoma). Diagnosis, screening and confirmation for viral hepatitis was done using a battery of techniques: ultrasound, conventional serological methods (Hepatitis B surface Antigen [HBsAg] - Reverse Passive Haemagglutination [RPHA], Hepatitis B core Antibody [HBcAb] - Passive Haemagglutination [PHA], Alpha-feto Protein - RPHA), Hepatitis B e Antigen/Antibody [HBeAg/Ab] - Radioimmunoassay [RIA], Hepatitis C antibody [HCV-Ab] - Enzyme Immunosorbent Assay [EIA]. Due to the high specificity and sensitivity of the Polymerase Chain Reaction technique [PCR] in detecting the viral genomes, it was used to establish the presence of the HBV-DNA and HCV-RNA to correlate the serological diagnosis of their respective seromarkers. A total of 39 serum samples were tested comprising 11 blood donors, 8 chronic liver disease patients and 20 hepatocellular carcinoma cases. 4/19 (21%) HCV-antibody (C-l) reactive samples were found to be positive for HCV-RNA by PCR. 14 of the 19 (73.7%) including the 4 HCV-RNA positive cases tested positive for HBcAb. 6 of 11 (55%) HBsAg positive cases also tested positive for HBV-DNA by PCR, In 8 of 20 (40%) hepatocellular carcinoma cases, no aetiological role could be assigned to hepatitis B or C as only HBcAb was demonstrated in those cases. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
